SCHEMBL5375690

SCHEMBL5375690

COc1ccc(COc2nc(SC)ns2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.45
KMT2A Q03164 3/20 0.45
NPC1 O15118 3/20 0.45
POLB P06746 2/20 0.45
APP P05067 5/20 0.43
MAOB P27338 1/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
IDO1 P14902 2/20 0.40
AGXT P21549 2/20 0.40
MEN1 O00255 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
PDE2A O00408 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378069 0.85 CYP1A2 (0.47) RAB9AKMT2ANPC1MAOBALDH1A1
SCHEMBL5417437 0.85 MEN1 (0.41) RAB9AKMT2ANPC1ALDH1A1LMNA
SCHEMBL5383575 0.84 APP (0.42) KMT2AAPPIDO1MEN1MAPK1
SCHEMBL5378052 0.84 MEN1 (0.41) RAB9AKMT2ANPC1POLBAPP
SCHEMBL5377692 0.84 MAPK1 (0.39) KMT2AALDH1A1MEN1MAPK1TDP1
SCHEMBL5377736 0.84 LMNA (0.47) RAB9AKMT2AALDH1A1LMNAMAPT
SCHEMBL5388491 0.82 CTSB (0.50) RAB9AKMT2ANPC1POLBALDH1A1
SCHEMBL5387366 0.82 APP (0.42) RAB9AKMT2APOLBAPPMAOB
SCHEMBL5373469 0.81 MAOB (0.41) RAB9AKMT2ANPC1POLBMAOB
SCHEMBL5389191 0.79 LMNA (0.46) RAB9AKMT2ANPC1POLBMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-20050215578-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-09-29 US disclosed
EP-1475374-A1 THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215578-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH RAB9A 1998/4885KMT2A 2219/4885NPC1 3108/4885
US-20070293510-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH RAB9A 2211/4885KMT2A 2234/4885NPC1 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.